← back to search

Teresa Peccerella

Heidelberg University · DE
Area of research
Epidemiology · Pathology and Forensic Medicine
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Liver Disease and Transplantation, and Iron Metabolism and Disorders.
h-index
17
citations
1,012
works
88
NIH funding
primary concept
Medicine
email

Recent publications

Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
Translational Oncology 2024cited by 3position: middledoi
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Nature Cancer 2023cited by 57position: middledoi
Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
Frontiers in Cell and Developmental Biology 2023cited by 3position: middledoi
Abstract A010: Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Cancer Research 2022cited by 3position: middledoi
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Frontiers in Cell and Developmental Biology 2021cited by 73position: middledoi
Chronic Ethanol Consumption and Generation of Etheno-DNA Adducts in Cancer-Prone Tissues
Advances in experimental medicine and biology 2018cited by 15position: firstdoi
Caspase‐cleaved keratin‐18 fragments increase during alcohol withdrawal and predict liver‐related death in patients with alcoholic liver disease
Hepatology 2017cited by 73position: middledoi
Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P‐4502E1 and Fibrosis
Alcoholism Clinical and Experimental Research 2017cited by 50position: middledoi
Sensitive and non-invasive assessment of hepatocellular iron using a novel room-temperature susceptometer
Journal of Hepatology 2017cited by 14position: middledoi
Possible Mechanisms of Ethanol‐Mediated Colorectal Carcinogenesis: The Role of Cytochrome P4502E1, Etheno‐<scp>DNA</scp> Adducts, and the Anti‐Apoptotic Protein Mcl‐1
Alcoholism Clinical and Experimental Research 2016cited by 10position: middledoi
Carcinogenic Etheno DNA-Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-450 and Fibrosis
Zeitschrift für Gastroenterologie 2016cited by 0position: middledoi
The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease.
PubMed 2015cited by 28position: middledoi
Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH).
PubMed 2015cited by 9position: middledoi
P1124 : Primary hepatocellular damage lowers alcohol consumption and suppresses peripheral fat mobilization in ALD patients with genetic variant I148M in PNPLA3
Journal of Hepatology 2015cited by 0position: middledoi
Histological hepatocyte damage precedes steatosis in ALD patients with genetic variant l148 M in PNPLA3
Zeitschrift für Gastroenterologie 2013cited by 1position: middledoi
Sustained Submicromolar H2O2 Levels Induce Hepcidin via Signal Transducer and Activator of Transcription 3 (STAT3)
Journal of Biological Chemistry 2012cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Helmut K. Seitz · Heidelberg University7 papers (2015–2018)Sebastian Mueller · Imperial College London7 papers (2012–2018)Helmut Bartsch · German Cancer Research Center6 papers (2015–2018)Beate K. Straub · Johannes Gutenberg University Mainz5 papers (2015–2017)Felix Stickel · Klinik Hirslanden5 papers (2013–2017)Xu Zhou · University Hospital Heidelberg4 papers (2021–2023)Thilo Hackert · HAW Hamburg4 papers (2021–2023)Vanessa Rausch · Heidelberg University4 papers (2013–2017)Christoph Springfeld · Université Grenoble Alpes4 papers (2021–2023)Markus W. Büchler · High Throughput Biology (United States)4 papers (2021–2023)John P. Neoptolemos · Hippocration General Hospital4 papers (2021–2023)Benedikt Brors · German Cancer Research Center4 papers (2021–2023)Roma Kurilov · German Cancer Research Center3 papers (2022–2023)Katharina Glassen · Heidelberg University3 papers (2015–2017)Jingyu An · University Hospital Heidelberg3 papers (2021–2023)Samuel Mueller · Macquarie University3 papers (2013–2016)Gunda Millonig · Salem Hospital3 papers (2012–2017) · 3 papers (2013–2017)Thomas Brückner · Zimmer Biomet (Netherlands)3 papers (2015–2017)Thomas Longerich · German Cancer Research Center3 papers (2015–2017)